FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and represents ophthalmic composition for relieving, treating or preventing a dry eye disorder comprising cyclosporine and trehalose as active ingredients, wherein weight ratio of cyclosporine:trehalose is equal to 1:20–200 and cyclosporine is present in amount of more than 0.01 wt. % to less than 1 wt. %, and trehalose is present in amount of more than 1 wt. % to 7.5 wt. % of calculation of total weight of composition.
EFFECT: invention provides a synergetic effect on preventing, relieving and treating dry eyes.
9 cl, 7 dwg, 1 tbl, 4 ex
